Scott E. Hadland, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues recommend that acute pain should be treated using a multimodal approach, including appropriate use of ...

HealthDay News — The overall second primary malignancy (SPM) point estimate was 5.8 percent for patients receiving chimeric antigen receptor (CAR) T-cell therapy, according to a study published online ...

Study compared telehealth with in-person meeting as a modality for effective delivery of early palliative care.

Researchers sought to determine whether complete remission with partial hematological recovery is beneficial in patients with AML.

Data suggest that neoadjuvant immune checkpoint inhibitor (ICI) therapy improves outcomes in patients with early-stage triple-negative breast cancer, but adjuvant ICI therapy does not.

Inotuzumab ozogamicin (InO) is an active antibody-drug conjugate that works by delivering the chemotherapeutic payload calicheamicin to cells expressing CD22. Studies demonstrate that InO elicits high ...

Population-based cohort study identifies better treatment objectives for women with advanced-stage ovarian cancer.

The incidence of head and neck cancer increased among patients in the cannabis-related disorder group compared with patients without cannabis-related disorder (0.285% vs 0.091%, respectively).

In a retrospective study, investigators compared the risk of progression to end-stage kidney disease (ESKD) following partial nephrectomy and radical nephrectomy among patients with preoperative stage ...

Similar cancer detection rates seen for transperineal versus transrectal biopsy, but reduction in infections seen for transperineal.

Researchers investigated characteristics of adolescent and young adult patients with HCC and risk factors that affect survival.

Researchers sought to determine whether ZA plus a proteasome inhibitor would reduce the risk of SREs in patients with MM.